Friday 16 October

Connecting Knowledge & People

Featured Topics

Article
NO LANDLINE, NO CLAIM: Eastern District Of Missouri Finds That Cellphones Aren’t Residential For DNC Purposes
The Eastern District of Missouri has ruled that cellphones are not covered under the TCPA's Do Not Call provisions, marking a significant departure from the majority rule. Following Florida's recent similar decision, the court determined that Congress intentionally excluded cellphones from residential telephone subscriber protections, challenging decades of FCC interpretation in the post-Loper Bright era.
United States Media & IT
Troutman Amin LLP
Article
Frontier AI And Federal Cybersecurity Oversight: Where Are We Now On U.S. AI Regulation?
The U.S. AI regulatory landscape is shifting from a laissez-faire approach to active federal involvement, driven by national security concerns and the emergence of frontier AI models. Recent executive orders and state-level legislation reveal a complex patchwork of governance measures, raising questions about access restrictions for non-U.S. organizations and the balance between innovation and security. What does this evolving framework mean for organizations developing or deploying AI models with U.S. expo
United States Technology
SM
Slaughter & May
Curated
CAPE Phase 3 Set For October 6 After Data-Validation Delay: What Importers Should Know
On February 20, 2026, the Supreme Court held that the International Emergency Economic Powers Act (IEEPA) does not authorize the President to impose tariffs. Learning Res., Inc. v. Trump, 607 U.S. 229, 255 (2026). The Supreme Court did not itself order refunds; the U.S. Court of International Trade (CIT) did, including an April 17 order directing U.S. Customs and Border Protection (CBP) to liquidate unliquidated IEEPA entries without those duties and to reliquidate liquidated entries without them, while suspending immediate compliance. Order at 3, V.O.S. Selections, Inc. v. United States, No. 25-00066, ECF No. 82 (Ct. Int’l Trade Apr. 17, 2026).
United States International
BG
Braumiller Law Group, PLLC
See more

Webinars

See More

Mondaq's Must Reads

Article
New York City’s Click-to-Cancel Rule: What Businesses Need To Know
New York City has enacted the nation's first municipal click-to-cancel rule, requiring businesses to provide clear disclosures, simple cancellation processes, and advance renewal notices for subscription services. With approximately 30 states already implementing similar regulations and the federal landscape in flux following the FTC's vacated rule, companies now face an increasingly complex patchwork of compliance obligations. The rule takes effect October 1, 2026, and imposes penalties ranging from $525 t
United States Consumer
SA
Skadden, Arps, Slate, Meagher & Flom (UK) LLP
Article
Get Ready Connecticut Employers: New Laws Take Effect October 1, 2026
Connecticut employers face significant changes to employment laws taking effect October 1, 2026, including expanded pay transparency requirements, new electronic monitoring notices, and AI-related disclosure obligations. The state legislature has amended multiple employment statutes affecting hiring practices, workplace monitoring, lactation accommodations, and employee protections. These changes require proactive policy reviews to ensure compliance and avoid civil penalties.
United States Employment
FH
Ford & Harrison LLP

Trending This Week on Mondaq

Highlighted Content

Food, Drugs, Healthcare, Life Sciences

Subscribe

Welcome to the Mondaq Food, Drugs, Healthcare, Life Sciences homepage, here you will find thought leadership articles, podcasts, videos and webinars providing insights covering topics such as Food and Drugs Law, Healthcare, Life Sciences, Biotechnology and Nanotechnology..

Article
The Race For Clinical Trials: Can The FDA’s New Pilot Program Stop The U.S. From Falling Behind?
The United States has lost approximately 10% of its global share of Phase 1 clinical trials since 2015, with China now accounting for 39% of all global trials by 2024. The FDA's new Expedited IND Pilot Program introduces Qualified Research Institutions and rolling submissions to help sponsors reach first-in-human dosing faster domestically. For life sciences companies whose financing depends on rapid trial initiation, this program could fundamentally reshape development strategy and restore U.S. competitive
United States Healthcare
FH
Foley Hoag LLP
Article
PBM Policy And Legislative Update — Fall 2026
Mintz's Managed Care, PBMs & Pharmacies practice examines critical federal and state developments impacting pharmacy benefit managers and the prescription drug supply chain from mid-February through June 2026. This comprehensive quarterly update analyzes legislative activity, regulatory changes, enforcement actions, and emerging market trends affecting PBMs, health plans, pharmacies, manufacturers, and industry stakeholders navigating an evolving regulatory landscape.
United States Healthcare
M
Mintz
Article
When FDA Oversees Trials Overseas: Foreign Clinical Trial Considerations
The FDA's acceptance of foreign clinical trial data hinges on strict compliance with good clinical practice standards, population representativeness, and data integrity requirements that sponsors must carefully navigate. As the agency intensifies scrutiny of non-U.S. trial sites and emphasizes demographic diversity in study populations, pharmaceutical companies face mounting challenges in ensuring their international research programs meet evolving regulatory expectations.
United States Healthcare
FH
Foley Hoag LLP
See more

Related Webinars

See More

Donald Trump Administration

Subscribe

Covers Donald Trump's Presidency, providing expert thought leadership across the various legal practice areas that may be impacted.

Including but not limited to Employment and HR, Immigration, International Law, Environment Law and Technology.

Article
Frontier AI And Federal Cybersecurity Oversight: Where Are We Now On U.S. AI Regulation?
The U.S. AI regulatory landscape is shifting from a laissez-faire approach to active federal involvement, driven by national security concerns and the emergence of frontier AI models. Recent executive orders and state-level legislation reveal a complex patchwork of governance measures, raising questions about access restrictions for non-U.S. organizations and the balance between innovation and security. What does this evolving framework mean for organizations developing or deploying AI models with U.S. expo
United States Technology
SM
Slaughter & May
Curated
CAPE Phase 3 Set For October 6 After Data-Validation Delay: What Importers Should Know
On February 20, 2026, the Supreme Court held that the International Emergency Economic Powers Act (IEEPA) does not authorize the President to impose tariffs. Learning Res., Inc. v. Trump, 607 U.S. 229, 255 (2026). The Supreme Court did not itself order refunds; the U.S. Court of International Trade (CIT) did, including an April 17 order directing U.S. Customs and Border Protection (CBP) to liquidate unliquidated IEEPA entries without those duties and to reliquidate liquidated entries without them, while suspending immediate compliance. Order at 3, V.O.S. Selections, Inc. v. United States, No. 25-00066, ECF No. 82 (Ct. Int’l Trade Apr. 17, 2026).
United States International
BG
Braumiller Law Group, PLLC
Article
Important ITAR Update For Syria: State Department Removes Syria From § 126.1 Proscribed Countries List
The U.S. Department of State has removed Syria from the list of countries subject to denial under the International Traffic in Arms Regulations (ITAR), marking a significant shift in defense export policy. While this change allows case-by-case review of license requests for defense articles and services, it does not constitute blanket authorization and requires careful navigation of remaining Export Administration Regulations and sanctions.
United States International
S
Steptoe LLP
See more

Latest Podcasts

Latest Videos

See more

Upcoming Events

Popular Contributors

Related Country Guides

F
Franchising
PC
Private Client
OG
Oil & Gas
I
Immigration
AB
Anti-Corruption & Bribery
PM
Private M&A
C
Cartels
TD
Tax Disputes
AF
Aviation Finance
MC
Merger Control
PP
Public Procurement
IA
International Arbitration